Name | (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]-N-ethylhept-5-enamide |
---|---|
Synonyms |
(5Z)-7-{(1R,2R,3R,5S)-2-[(1E)-3,3-Difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl}-N-ethyl-5-heptenamide
unii-jjg9y3yd25 5-Heptenamide, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-N-ethyl-, (5Z)- Tafluprost ethyl amide |
Description | Tafluprost ethyl amide is a prostaglandin derivative. Tafluprost ethyl amide is capable of intraocular pressure (IOP) reduction and influencing eyelash growth. Tafluprost ethyl amide can be used in antiglaucoma ophthalmic compositions or cosmetics[1]. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 609.3±55.0 °C at 760 mmHg |
Molecular Formula | C24H33F2NO4 |
Molecular Weight | 437.520 |
Flash Point | 322.3±31.5 °C |
Exact Mass | 437.237762 |
PSA | 78.79000 |
LogP | 2.66 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.559 |